7-(1,3-dimethylimidazol-1-ium-2-yl)-8-methylindolizine;(2S)-1,2-dimethyl-3-(8-methylindolizin-1-yl)-2H-benzimidazole;1,3-dimethyl-2-(7-methylindolizin-8-yl)benzimidazol-3-ium;1-[1-(2,6-dimethylphenyl)-3-methylimidazol-3-ium-2-yl]-2-methylindolizine;2-methyl-1-(1-methylindolizin-8-yl)-[1]benzofuro[2,3-c]pyridin-2-ium;3-methyl-2-(2-methylpyrazol-2-ium-1-yl)indolizine

C105H106N17O+5 — CID 159133761

IUPAC7-(1,3-dimethylimidazol-1-ium-2-yl)-8-methylindolizine;(2S)-1,2-dimethyl-3-(8-methylindolizin-1-yl)-2H-benzimidazole;1,3-dimethyl-2-(7-methylindolizin-8-yl)benzimidazol-3-ium;1-[1-(2,6-dimethylphenyl)-3-methylimidazol-3-ium-2-yl]-2-methylindolizine;2-methyl-1-(1-methylindolizin-8-yl)-[1]benzofuro[2,3-c]pyridin-2-ium;3-methyl-2-(2-methylpyrazol-2-ium-1-yl)indolizine
SMILESCc1c(-c2n(C)cc[n+]2C)ccn2cccc12.Cc1c(-n2ccc[n+]2C)cc2ccccn12.Cc1cccc(C)c1-n1cc[n+](C)c1-c1c(C)cn2ccccc12.Cc1cccn2ccc(N3c4ccccc4N(C)[C@@H]3C)c12.Cc1ccn2cccc(-c3c4oc5ccccc5c4cc[n+]3C)c12.Cc1ccn2cccc2c1-c1n(C)c2ccccc2[n+]1C
InChIInChI=1S/C21H22N3.C21H17N2O.C18H19N3.C18H18N3.C14H16N3.C13H14N3/c1-15-8-7-9-16(2)20(15)24-13-12-22(4)21(24)19-17(3)14-23-11-6-5-10-18(19)23;1-14-9-13-23-11-5-7-17(19(14)23)20-21-16(10-12-22(20)2)15-6-3-4-8-18(15)24-21;1-13-7-6-11-20-12-10-17(18(13)20)21-14(2)19(3)15-8-4-5-9-16(15)21;1-13-10-12-21-11-6-9-16(21)17(13)18-19(2)14-7-4-5-8-15(14)20(18)3;1-11-12(14-15(2)9-10-16(14)3)6-8-17-7-4-5-13(11)17;1-11-13(16-9-5-7-14(16)2)10-12-6-3-4-8-15(11)12/h5-14H,1-4H3;3-13H,1-2H3;4-12,14H,1-3H3;4-12H,1-3H3;4-10H,1-3H3;3-10H,1-2H3/q2*+1;;3*+1/t;;14-;;;/m..0.../s1
InChIKeySSWILMPDOKSXMS-IPBPGIEUSA-N
MW1622.12 g/mol
LogP20.14
Rot. Bonds7

About 7-(1,3-dimethylimidazol-1-ium-2-yl)-8-methylindolizine;(2S)-1,2-dimethyl-3-(8-methylindolizin-1-yl)-2H-benzimidazole;1,3-dimethyl-2-(7-methylindolizin-8-yl)benzimidazol-3-ium;1-[1-(2,6-dimethylphenyl)-3-methylimidazol-3-ium-2-yl]-2-methylindolizine;2-methyl-1-(1-methylindolizin-8-yl)-[1]benzofuro[2,3-c]pyridin-2-ium;3-methyl-2-(2-methylpyrazol-2-ium-1-yl)indolizine

7-(1,3-dimethylimidazol-1-ium-2-yl)-8-methylindolizine;(2S)-1,2-dimethyl-3-(8-methylindolizin-1-yl)-2H-benzimidazole;1,3-dimethyl-2-(7-methylindolizin-8-yl)benzimidazol-3-ium;1-[1-(2,6-dimethylphenyl)-3-methylimidazol-3-ium-2-yl]-2-methylindolizine;2-methyl-1-(1-methylindolizin-8-yl)-[1]benzofuro[2,3-c]pyridin-2-ium;3-methyl-2-(2-methylpyrazol-2-ium-1-yl)indolizine (PubChem CID 159133761) has the molecular formula C105H106N17O+5 and a molecular weight of 1622.12 g/mol. Its IUPAC name is 7-(1,3-dimethylimidazol-1-ium-2-yl)-8-methylindolizine;(2S)-1,2-dimethyl-3-(8-methylindolizin-1-yl)-2H-benzimidazole;1,3-dimethyl-2-(7-methylindolizin-8-yl)benzimidazol-3-ium;1-[1-(2,6-dimethylphenyl)-3-methylimidazol-3-ium-2-yl]-2-methylindolizine;2-methyl-1-(1-methylindolizin-8-yl)-[1]benzofuro[2,3-c]pyridin-2-ium;3-methyl-2-(2-methylpyrazol-2-ium-1-yl)indolizine.

Molecular Properties

Compound Name7-(1,3-dimethylimidazol-1-ium-2-yl)-8-methylindolizine;(2S)-1,2-dimethyl-3-(8-methylindolizin-1-yl)-2H-benzimidazole;1,3-dimethyl-2-(7-methylindolizin-8-yl)benzimidazol-3-ium;1-[1-(2,6-dimethylphenyl)-3-methylimidazol-3-ium-2-yl]-2-methylindolizine;2-methyl-1-(1-methylindolizin-8-yl)-[1]benzofuro[2,3-c]pyridin-2-ium;3-methyl-2-(2-methylpyrazol-2-ium-1-yl)indolizine
PubChem CID159133761
Molecular FormulaC105H106N17O+5
Molecular Weight1622.12 g/mol
Exact Mass1620.87
IUPAC Name7-(1,3-dimethylimidazol-1-ium-2-yl)-8-methylindolizine;(2S)-1,2-dimethyl-3-(8-methylindolizin-1-yl)-2H-benzimidazole;1,3-dimethyl-2-(7-methylindolizin-8-yl)benzimidazol-3-ium;1-[1-(2,6-dimethylphenyl)-3-methylimidazol-3-ium-2-yl]-2-methylindolizine;2-methyl-1-(1-methylindolizin-8-yl)-[1]benzofuro[2,3-c]pyridin-2-ium;3-methyl-2-(2-methylpyrazol-2-ium-1-yl)indolizine
SMILESCc1c(-c2n(C)cc[n+]2C)ccn2cccc12.Cc1c(-n2ccc[n+]2C)cc2ccccn12.Cc1cccc(C)c1-n1cc[n+](C)c1-c1c(C)cn2ccccc12.Cc1cccn2ccc(N3c4ccccc4N(C)[C@@H]3C)c12.Cc1ccn2cccc(-c3c4oc5ccccc5c4cc[n+]3C)c12.Cc1ccn2cccc2c1-c1n(C)c2ccccc2[n+]1C
InChIInChI=1S/C21H22N3.C21H17N2O.C18H19N3.C18H18N3.C14H16N3.C13H14N3/c1-15-8-7-9-16(2)20(15)24-13-12-22(4)21(24)19-17(3)14-23-11-6-5-10-18(19)23;1-14-9-13-23-11-5-7-17(19(14)23)20-21-16(10-12-22(20)2)15-6-3-4-8-18(15)24-21;1-13-7-6-11-20-12-10-17(18(13)20)21-14(2)19(3)15-8-4-5-9-16(15)21;1-13-10-12-21-11-6-9-16(21)17(13)18-19(2)14-7-4-5-8-15(14)20(18)3;1-11-12(14-15(2)9-10-16(14)3)6-8-17-7-4-5-13(11)17;1-11-13(16-9-5-7-14(16)2)10-12-6-3-4-8-15(11)12/h5-14H,1-4H3;3-13H,1-2H3;4-12,14H,1-3H3;4-12H,1-3H3;4-10H,1-3H3;3-10H,1-2H3/q2*+1;;3*+1/t;;14-;;;/m..0.../s1
InChIKeySSWILMPDOKSXMS-IPBPGIEUSA-N
XLogP20.14
TPSA85.20 Ų
H-Bond Donors
H-Bond Acceptors13
Rotatable Bonds7
Heavy Atoms123
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001622.12
LogP ≤ 520.14
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}

Analyze 7-(1,3-dimethylimidazol-1-ium-2-yl)-8-methylindolizine;(2S)-1,2-dimethyl-3-(8-methylindolizin-1-yl)-2H-benzimidazole;1,3-dimethyl-2-(7-methylindolizin-8-yl)benzimidazol-3-ium;1-[1-(2,6-dimethylphenyl)-3-methylimidazol-3-ium-2-yl]-2-methylindolizine;2-methyl-1-(1-methylindolizin-8-yl)-[1]benzofuro[2,3-c]pyridin-2-ium;3-methyl-2-(2-methylpyrazol-2-ium-1-yl)indolizine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 7-(1,3-dimethylimidazol-1-ium-2-yl)-8-methylindolizine;(2S)-1,2-dimethyl-3-(8-methylindolizin-1-yl)-2H-benzimidazole;1,3-dimethyl-2-(7-methylindolizin-8-yl)benzimidazol-3-ium;1-[1-(2,6-dimethylphenyl)-3-methylimidazol-3-ium-2-yl]-2-methylindolizine;2-methyl-1-(1-methylindolizin-8-yl)-[1]benzofuro[2,3-c]pyridin-2-ium;3-methyl-2-(2-methylpyrazol-2-ium-1-yl)indolizine?
The IUPAC name of 7-(1,3-dimethylimidazol-1-ium-2-yl)-8-methylindolizine;(2S)-1,2-dimethyl-3-(8-methylindolizin-1-yl)-2H-benzimidazole;1,3-dimethyl-2-(7-methylindolizin-8-yl)benzimidazol-3-ium;1-[1-(2,6-dimethylphenyl)-3-methylimidazol-3-ium-2-yl]-2-methylindolizine;2-methyl-1-(1-methylindolizin-8-yl)-[1]benzofuro[2,3-c]pyridin-2-ium;3-methyl-2-(2-methylpyrazol-2-ium-1-yl)indolizine (CID 159133761) is 7-(1,3-dimethylimidazol-1-ium-2-yl)-8-methylindolizine;(2S)-1,2-dimethyl-3-(8-methylindolizin-1-yl)-2H-benzimidazole;1,3-dimethyl-2-(7-methylindolizin-8-yl)benzimidazol-3-ium;1-[1-(2,6-dimethylphenyl)-3-methylimidazol-3-ium-2-yl]-2-methylindolizine;2-methyl-1-(1-methylindolizin-8-yl)-[1]benzofuro[2,3-c]pyridin-2-ium;3-methyl-2-(2-methylpyrazol-2-ium-1-yl)indolizine.
What is the SMILES notation for 7-(1,3-dimethylimidazol-1-ium-2-yl)-8-methylindolizine;(2S)-1,2-dimethyl-3-(8-methylindolizin-1-yl)-2H-benzimidazole;1,3-dimethyl-2-(7-methylindolizin-8-yl)benzimidazol-3-ium;1-[1-(2,6-dimethylphenyl)-3-methylimidazol-3-ium-2-yl]-2-methylindolizine;2-methyl-1-(1-methylindolizin-8-yl)-[1]benzofuro[2,3-c]pyridin-2-ium;3-methyl-2-(2-methylpyrazol-2-ium-1-yl)indolizine?
The canonical SMILES for 7-(1,3-dimethylimidazol-1-ium-2-yl)-8-methylindolizine;(2S)-1,2-dimethyl-3-(8-methylindolizin-1-yl)-2H-benzimidazole;1,3-dimethyl-2-(7-methylindolizin-8-yl)benzimidazol-3-ium;1-[1-(2,6-dimethylphenyl)-3-methylimidazol-3-ium-2-yl]-2-methylindolizine;2-methyl-1-(1-methylindolizin-8-yl)-[1]benzofuro[2,3-c]pyridin-2-ium;3-methyl-2-(2-methylpyrazol-2-ium-1-yl)indolizine is Cc1c(-c2n(C)cc[n+]2C)ccn2cccc12.Cc1c(-n2ccc[n+]2C)cc2ccccn12.Cc1cccc(C)c1-n1cc[n+](C)c1-c1c(C)cn2ccccc12.Cc1cccn2ccc(N3c4ccccc4N(C)[C@@H]3C)c12.Cc1ccn2cccc(-c3c4oc5ccccc5c4cc[n+]3C)c12.Cc1ccn2cccc2c1-c1n(C)c2ccccc2[n+]1C.
What is the InChIKey of 7-(1,3-dimethylimidazol-1-ium-2-yl)-8-methylindolizine;(2S)-1,2-dimethyl-3-(8-methylindolizin-1-yl)-2H-benzimidazole;1,3-dimethyl-2-(7-methylindolizin-8-yl)benzimidazol-3-ium;1-[1-(2,6-dimethylphenyl)-3-methylimidazol-3-ium-2-yl]-2-methylindolizine;2-methyl-1-(1-methylindolizin-8-yl)-[1]benzofuro[2,3-c]pyridin-2-ium;3-methyl-2-(2-methylpyrazol-2-ium-1-yl)indolizine?
The InChIKey is SSWILMPDOKSXMS-IPBPGIEUSA-N. The full InChI is InChI=1S/C21H22N3.C21H17N2O.C18H19N3.C18H18N3.C14H16N3.C13H14N3/c1-15-8-7-9-16(2)20(15)24-13-12-22(4)21(24)19-17(3)14-23-11-6-5-10-18(19)23;1-14-9-13-23-11-5-7-17(19(14)23)20-21-16(10-12-22(20)2)15-6-3-4-8-18(15)24-21;1-13-7-6-11-20-12-10-17(18(13)20)21-14(2)19(3)15-8-4-5-9-16(15)21;1-13-10-12-21-11-6-9-16(21)17(13)18-19(2)14-7-4-5-8-15(14)20(18)3;1-11-12(14-15(2)9-10-16(14)3)6-8-17-7-4-5-13(11)17;1-11-13(16-9-5-7-14(16)2)10-12-6-3-4-8-15(11)12/h5-14H,1-4H3;3-13H,1-2H3;4-12,14H,1-3H3;4-12H,1-3H3;4-10H,1-3H3;3-10H,1-2H3/q2*+1;;3*+1/t;;14-;;;/m..0.../s1.
What are the key properties of 7-(1,3-dimethylimidazol-1-ium-2-yl)-8-methylindolizine;(2S)-1,2-dimethyl-3-(8-methylindolizin-1-yl)-2H-benzimidazole;1,3-dimethyl-2-(7-methylindolizin-8-yl)benzimidazol-3-ium;1-[1-(2,6-dimethylphenyl)-3-methylimidazol-3-ium-2-yl]-2-methylindolizine;2-methyl-1-(1-methylindolizin-8-yl)-[1]benzofuro[2,3-c]pyridin-2-ium;3-methyl-2-(2-methylpyrazol-2-ium-1-yl)indolizine?
7-(1,3-dimethylimidazol-1-ium-2-yl)-8-methylindolizine;(2S)-1,2-dimethyl-3-(8-methylindolizin-1-yl)-2H-benzimidazole;1,3-dimethyl-2-(7-methylindolizin-8-yl)benzimidazol-3-ium;1-[1-(2,6-dimethylphenyl)-3-methylimidazol-3-ium-2-yl]-2-methylindolizine;2-methyl-1-(1-methylindolizin-8-yl)-[1]benzofuro[2,3-c]pyridin-2-ium;3-methyl-2-(2-methylpyrazol-2-ium-1-yl)indolizine has a molecular weight of 1622.12 g/mol, XLogP of 20.14, 7 rotatable bonds, 0 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 7-(1,3-dimethylimidazol-1-ium-2-yl)-8-methylindolizine;(2S)-1,2-dimethyl-3-(8-methylindolizin-1-yl)-2H-benzimidazole;1,3-dimethyl-2-(7-methylindolizin-8-yl)benzimidazol-3-ium;1-[1-(2,6-dimethylphenyl)-3-methylimidazol-3-ium-2-yl]-2-methylindolizine;2-methyl-1-(1-methylindolizin-8-yl)-[1]benzofuro[2,3-c]pyridin-2-ium;3-methyl-2-(2-methylpyrazol-2-ium-1-yl)indolizine is sourced from PubChem (CID 159133761), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).